Join
Live feed
·
INSIDERFilingvia Quantisnow
Quince Therapeutics Inc. logo

Lamond David bought $69,233 worth of shares (67,881 units at $1.02), increasing direct ownership by 0.98% to 2,302,291 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
QNCX· Quince Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QNCX (Quince Therapeutics Inc.) and more on Quantisnow.